We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-3.64%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$300B
AUM Growth
-$49.2B
Cap. Flow
-$29.5B
Cap. Flow %
-9.85%
Top 10 Hldgs %
13.34%
Holding
11,668
New
1,182
Increased
3,623
Reduced
5,175
Closed
1,160

Sector Composition

Rank Sector Weight
1 Technology 13.08%
2 Financials 7.19%
3 Healthcare 6.35%
4 Consumer Discretionary 5.55%
5 Industrials 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOLT icon
9201
Bolt Biotherapeutics
BOLT
$7.67M
$4K ﹤0.01%
79
+78
+7,800% +$5.25K
BTAL icon
9202
AGF US Market Neutral Anti-Beta Fund
BTAL
$304M
$4K ﹤0.01%
+233
New +$4.29K
BWMX icon
9203
Betterware México
BWMX
$634M
$4K ﹤0.01%
234
-4,162
-95% -$80.7K
CIFRW
9204
DELISTED
Cipher Mining Warrant
CIFRW
$4K ﹤0.01%
6,248
+3,646
+140% +$2.39K
CMMB
9205
Chemomab Therapeutics
CMMB
$11.4M
$4K ﹤0.01%
221
-240
-52% -$4.73K
COE
9206
51Talk Online Education Group
COE
$106M
$4K ﹤0.01%
520
-684
-57% -$3.47K
CPHI icon
9207
China Pharma Holdings
CPHI
$45M
$4K ﹤0.01%
+19
New +$3.97K
CTRM icon
9208
Castor Maritime
CTRM
$18.8M
$4K ﹤0.01%
197
-1,784
-90% -$27.6K
CWAN
9209
DELISTED
Clearwater Analytics
CWAN
$4K ﹤0.01%
176
-1,472
-89% -$27.5K
BGMSP
9210
DELISTED
Bio Green Med Solution Inc Preferred Stock
BGMSP
$4K ﹤0.01%
629
-48
-7% -$320
CYCN icon
9211
Cyclerion Therapeutics
CYCN
$14.9M
$4K ﹤0.01%
+182
New +$4.38K
DRV icon
9212
Direxion Daily Real Estate Bear 3X ETF
DRV
$26.5M
$4K ﹤0.01%
123
-1,142
-90% -$46.6K
DTIL icon
9213
Precision BioSciences
DTIL
$180M
$4K ﹤0.01%
38
-4,762
-99% -$647K
DURA icon
9214
VanEck Durable High Dividend ETF
DURA
$38.6M
$4K ﹤0.01%
126
-3,101
-96% -$98.8K
EQS icon
9215
Equus Total Return
EQS
$16.2M
$4K ﹤0.01%
1,686
+1,477
+707% +$3.72K
EZGO
9216
EZGO Technologies
EZGO
$2.09M
0
FBCG
9217
DELISTED
Fidelity Blue Chip Growth ETF
FBCG
$4K ﹤0.01%
141
FWDI
9218
Forward Industries Inc
FWDI
$297M
$4K ﹤0.01%
232
-526
-69% -$8.39K
GBUY
9219
DELISTED
Goldman Sachs Future Consumer Equity ETF
GBUY
$4K ﹤0.01%
121
+4
+3% +$130
GCMGW
9220
DELISTED
GCM Grosvenor Inc Warrant
GCMGW
$4K ﹤0.01%
3,027
+2,609
+624% +$3.18K
GLRY icon
9221
Inspire Growth ETF
GLRY
$168M
$4K ﹤0.01%
162
+130
+406% +$3.35K
GNFT
9222
DELISTED
Genfit
GNFT
$4K ﹤0.01%
1,103
-26
-2% -$106
GTIM icon
9223
Good Times Restaurants
GTIM
$14.6M
$4K ﹤0.01%
1,004
-2,226
-69% -$9.43K
HOOK
9224
DELISTED
HOOKIPA Pharma
HOOK
$4K ﹤0.01%
165
-818
-83% -$14.7K
KELYB
9225
Kelly Services Class B
KELYB
$765M
$4K ﹤0.01%
209
+87
+71% +$1.75K

Similar funds

UBS Group's Q1 2022 Portfolio in Review

As of Q1 2022, UBS Group held 11,668 positions worth $300B, down 14% from $349B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group withdrew a net $29.5B in Q1 2022, closing 1,160 positions and reducing 5,175 holdings. Its most notable exit was Xilinx Inc, an estimated $186M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS Group opened a new position in Shell worth $66.6M.

  • UBS Group's largest Q1 2022 buy was Shell: 1,213,213 shares worth $66.6M.
  • UBS Group added most to Tesla in Q1 2022, an estimated $388M increase.
  • UBS Group's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $911M.
  • UBS Group fully exited Xilinx Inc in Q1 2022, selling an estimated $186M.
  • UBS Group's ten largest holdings make up 13% of its $300B portfolio in Q1 2022.
  • UBS Group opened 1,182 new positions and closed 1,160 in Q1 2022.
  • UBS Group's portfolio value fell 14% quarter-over-quarter to $300B.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.